We are monitoring the impact of COVID-19 on APAC Testosterone Replacement Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4422
Share on
Share on

APAC Testosterone Replacement Therapy Market Research Report – Segmented By Product Type, Active Ingredient and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Size, Share, Trends and Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 4422
Pages: 145

The size of the Testosterone Replacement Therapy Market in the Asia Pacific is estimated to witness a prominent CAGR from 2020 to 2025.

Testosterone Replacement Therapy (TRT) is a category of hormone replacement therapy in which androgens such as testosterone, are replaced. Testosterone Replacement Therapy is often prescribed to counter the repercussions of male hypogonadism.

Testosterone Replacement Therapy typically involves the administration of testosterone through injections, patches, gels, skin creams, or subcutaneous pellets. TRT is the classic treatment of hypogonadism and may improve its symptoms such as fatigue and anaemia. Also, a number of other effects of testosterone have led to research into possible therapeutic roles in: erectile dysfunction, osteoporosis, chronic heart failure, diabetes mellitus, dementia and hormone replacement therapy for transgender men. Usage of Testosterone Replacement Therapy has become increasingly popular and has many controversies attached to it in the modern days.

The key driving factor of Asia Pacific Testosterone Replacement Therapy Industry is growing number of people being affected by testosterone deficiency problem. As the occurrence of such cases grow in number, the demand for testosterone replacement therapy is also expected to rise subsequently. Along with this major factor, another important propelling factor for the growth of the Asia Pacific testosterone replacement therapy market is the growing geriatric population at a steady pace. It is forecasted that number of men reporting deficiency of testosterone will rise across the world as the geriatric population will rise. In addition to these factors, there is an increasing awareness among the world population about the testosterone deficiency and they are taking measures to solve the problem, which will help in the growth of this market.

However, the market is constrained by factors such as side effects which are associated with therapy such as metabolic and cardiovascular ailments.

The Asia Pacific Testosterone Replacement Therapy Market Segmentation based on product type into patches, injections, adhesives, implants and oral. By active ingredient type, the market is categorised into testosterone undecanoate, testosterone enanthate, testosterone cypionate, methyl testosterone and testosterone.

Asia Pacific region has the third largest market for testosterone replacement therapy in the world by share, and is the fastest growing region in the world owing to factors such as huge population base among others. Factors such as growing geriatric population and rising incidence of hypogonadism is expected to propel the market growth in this region.

Companies playing a key role in the APAC Testosterone Replacement Therapy market covered in this report are Pfizer Inc., Allergan Plc., AbbVie Inc., Bayer AG., Eli Lilly and Company, Endo Pharmaceuticals, Kyowa Kirin International Plc., Novartis AG. and Mylan N.V. among others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product Type                             

                                5.1.1 Patches    

                                5.1.2 Injections

                                5.1.3 Adhesives               

                                5.1.4 Implants   

                                5.1.5 Oral            

                                5.1.6  Y-o-Y Growth Analysis, By Product Type   

                                5.1.7  Market Attractiveness Analysis, By Product Type                 

                                5.1.8  Market Share Analysis, By Product Type   

                5.2 Active Ingredient                     

                                5.2.1 Testosterone Undecanoate            

                                5.2.2 Testosterone Enanthate   

                                5.2.3 Testosterone Cypionate   

                                5.2.4 Methyl Testosterone         

                                5.2.5 Active Ingredient                 

                                5.2.6 Y-o-Y Growth Analysis, By Active Ingredient            

                                5.2.7 Market Attractiveness Analysis, By Active Ingredient          

                                5.2.8 Market Share Analysis, By Active Ingredient            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Product Type

                                                6.1.3.2 By Active Ingredient

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Product Type

                                                6.1.4.2 By Active Ingredient

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Product Type

                                                6.1.5.2 By Active Ingredient

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Pfizer Inc.                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Allergan Plc.                               

                8.3 AbbVie Inc.                 

                8.4 Bayer AG.                    

                8.5 Eli Lilly and Company                              

                8.6 Endo Pharmaceuticals                            

                8.7 Kyowa Kirin International Plc.                             

                8.8 Novartis AG.                              

                8.9 Mylan N.V.                 

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by type, packaging and meat type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the North america market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Asia Pacific Testosterone Replacement Therapy Market, By Product Type, From 2020 to 2025 (USD Million)
  2. Asia Pacific Patches Market, By Region, From 2020 to 2025 (USD Million)
  3. Asia Pacific Injections Market, By Region, From 2020 to 2025 (USD Million)
  4. Asia Pacific Adhesives Market, By Region, From 2020 to 2025 (USD Million)
  5. Asia Pacific Implants  Market, By Region, From 2020 to 2025 (USD Million)
  6. Asia Pacific Oral Market, By Region, From 2020 to 2025 (USD Million)
  7. Asia Pacific Testosterone Replacement Therapy Market, By Active Ingredient, From 2020 to 2025 (USD Million)
  8. Asia Pacific Testosterone Undecanoate Market, By Region, From 2020 to 2025 (USD Million)
  9. Asia Pacific Testosterone Enanthate Market, By Region, From 2020 to 2025 (USD Million)
  10. Asia Pacific Testosterone Cypionate Market, By Region, From 2020 to 2025 (USD Million)
  11. Asia Pacific Methyl Testosterone  Market, By Region, From 2020 to 2025 (USD Million)
  12. Asia Pacific Testosterone Market, By Region, From 2020 to 2025 (USD Million)
  13. Japan Testosterone Replacement Therapy Market, By Product Type, From 2020 to 2025 (USD Million)
  14. Japan Testosterone Replacement Therapy Market, By Active Ingredient, From 2020 to 2025 (USD Million)
  15. China Testosterone Replacement Therapy Market, By Product Type, From 2020 to 2025 (USD Million)
  16. China Testosterone Replacement Therapy Market, By Active Ingredient, From 2020 to 2025 (USD Million)
  17. India Testosterone Replacement Therapy Market, By Product Type, From 2020 to 2025 (USD Million)
  18. India Testosterone Replacement Therapy Market, By Active Ingredient, From 2020 to 2025 (USD Million)
  19. Australia Testosterone Replacement Therapy Market, By Product Type, From 2020 to 2025 (USD Million)
  20. Australia Testosterone Replacement Therapy Market, By Active Ingredient, From 2020 to 2025 (USD Million)
  21. South Korea Testosterone Replacement Therapy Market, By Product Type, From 2020 to 2025 (USD Million)
  22. South Korea Testosterone Replacement Therapy Market, By Active Ingredient, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample